New therapy aims to halt type 1 diabetes progression in select patients
Disease control
Ongoing
This Phase 3 trial is testing whether injections of an investigational drug called Diamyd, given directly into a lymph node, can help preserve the body's remaining insulin-producing cells in people recently diagnosed with type 1 diabetes. The study is for adolescents and young ad…
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated Mar 27, 2026 12:42 UTC